Search results
Regeneron touts success with bispecific antibody in multiple myeloma trial
Clinical Trials Arena via Yahoo Finance· 4 hours agoRegeneron said that the therapy is under review by the US Food and Drug Administration. In addition,...
Corus CEO Doug Murphy Exits After Losing Warner Bros. Discovery Channels
The Hollywood Reporter via Yahoo Finance· 7 hours agoCorus Entertainment has replaced president and CEO Doug Murphy with co-CEOs a week after the...
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 4 days agoMore companies, like Pfizer Amgen and Roche, are now in the mix as well. Lilly scientists have about...
“We’ve got to step up and help these companies get to that next level” – new investor Ahimsa...
Just Food via Yahoo Finance· 5 days agoMatt Tullman, one of Ahimsa Companies’ investors and its CEO, talks the recent slowdown in the...
This nutrition scientist is on a mission to make ultra-processed foods healthier. Can he succeed?
INSIDER via Yahoo News· 2 days ago(Already, big food companies including Nestle are refomulating some packaged foods like frozen...
Top 6 Movies That Celebrate Fatherhood
Momtastic via Yahoo News· 19 hours agoWhile good food and a lovely gift must be at the top of your list, how about spending Father’s Day evening with your dad by watching movies celebrating...
Russia accused of using hunger as a weapon of war in Ukraine
KEYT 3 Santa Barbara· 4 days agoIt found that Russian forces “systematically attacked objects indispensable to the survival of the civilian population,” while at the same time cutting off evacuation routes ...
Video Shows Uncontacted Tribe Beg For Food From Miners Who Destroy Their Land
IFLScience· 4 days agoA shocking new video shows members of an uncontacted tribe in Indonesia approach the miners who are...
GREG GUTFELD: DEI doesn't bring Americans together, it divides us
Fox News· 4 days ago"Gutfeld!" host Greg Gutfeld applauds efforts by Republicans to "eliminate diversity, equity and...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 5 days agoPfizer also recently said its new drug, Adcetris, improved overall survival, progression-free ...